241 related articles for article (PubMed ID: 27863360)
1. The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.
Fukuta H; Goto T; Wakami K; Ohte N
Int J Cardiol; 2017 Feb; 228():4-10. PubMed ID: 27863360
[TBL] [Abstract][Full Text] [Related]
2. Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies.
Fukuta H; Goto T; Wakami K; Ohte N
Heart Fail Rev; 2017 Nov; 22(6):775-782. PubMed ID: 28702858
[TBL] [Abstract][Full Text] [Related]
3. The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
Fukuta H; Goto T; Wakami K; Ohte N
Int J Cardiol; 2016 Jul; 214():301-6. PubMed ID: 27082778
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis.
Bavishi C; Chatterjee S; Ather S; Patel D; Messerli FH
Heart Fail Rev; 2015 Mar; 20(2):193-201. PubMed ID: 25034701
[TBL] [Abstract][Full Text] [Related]
5. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
Heart Fail Rev; 2021 Jan; 26(1):165-171. PubMed ID: 32743714
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis.
Liu F; Chen Y; Feng X; Teng Z; Yuan Y; Bin J
PLoS One; 2014; 9(3):e90555. PubMed ID: 24599093
[TBL] [Abstract][Full Text] [Related]
8. Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.
Arnold SV; Silverman DN; Gosch K; Nassif ME; Infeld M; Litwin S; Meyer M; Fendler TJ
JACC Heart Fail; 2023 Aug; 11(8 Pt 1):893-900. PubMed ID: 37140513
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction.
Park JJ; Choi HM; Hwang IC; Park JB; Park JH; Cho GY
J Am Soc Echocardiogr; 2019 Nov; 32(11):1462-1469.e8. PubMed ID: 31540679
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis.
Kaddoura R; Madurasinghe V; Chapra A; Abushanab D; Al-Badriyeh D; Patel A
Curr Probl Cardiol; 2024 Mar; 49(3):102376. PubMed ID: 38184132
[TBL] [Abstract][Full Text] [Related]
11. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
Silverman DN; Plante TB; Infeld M; Callas PW; Juraschek SP; Dougherty GB; Meyer M
JAMA Netw Open; 2019 Dec; 2(12):e1916598. PubMed ID: 31800067
[TBL] [Abstract][Full Text] [Related]
12. Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Wu M; Ni D; Huang LL; Qiu S
Clin Cardiol; 2023 Aug; 46(8):845-852. PubMed ID: 37272188
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.
Ruiz G; Andrey JL; Puerto JL; Escobar MA; Romero SP; Aranda R; Pedrosa MJ; Gomez F
Int J Cardiol; 2016 Nov; 222():594-602. PubMed ID: 27513657
[TBL] [Abstract][Full Text] [Related]
14. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Fukuta H; Goto T; Wakami K; Ohte N
Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
[TBL] [Abstract][Full Text] [Related]
15. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison.
Bonsu KO; Arunmanakul P; Chaiyakunapruk N
Heart Fail Rev; 2018 Mar; 23(2):147-156. PubMed ID: 29411216
[TBL] [Abstract][Full Text] [Related]
17. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
18. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction.
Farasat SM; Bolger DT; Shetty V; Menachery EP; Gerstenblith G; Kasper EK; Najjar SS
Am J Cardiol; 2010 Jan; 105(2):229-34. PubMed ID: 20102924
[TBL] [Abstract][Full Text] [Related]
19. Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis.
Halabi A; Sen J; Huynh Q; Marwick TH
Cardiovasc Diabetol; 2020 Aug; 19(1):124. PubMed ID: 32758236
[TBL] [Abstract][Full Text] [Related]
20. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
Lam PH; Gupta N; Dooley DJ; Singh S; Deedwania P; Zile MR; Bhatt DL; Morgan CJ; Pitt B; Fonarow GC; Ahmed A
Am J Med; 2018 Dec; 131(12):1473-1481. PubMed ID: 30076815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
